Trade-Ideas: Rockwell Medical (RMTI) Is Today's "Perilous Reversal" Stock
- RMTI has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $40.0 million.
- RMTI has traded 91,195 shares today.
- RMTI is down 3.3% today.
- RMTI was up 5.9% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in RMTI with the Ticky from Trade-Ideas. See the FREE profile for RMTI NOW at Trade-Ideas More details on RMTI: Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. Currently there are 3 analysts that rate Rockwell Medical a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Rockwell Medical has been 2.2 million shares per day over the past 30 days. Rockwell Medical has a market cap of $367.2 million and is part of the health care sector and drugs industry. The stock has a beta of 1.33 and a short float of 43.8% with 1.81 days to cover. Shares are up 14.3% year to date as of the close of trading on Monday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Rockwell Medical as a sell. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins, weak operating cash flow and generally high debt management risk. Highlights from the ratings report include:
- Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Equipment & Supplies industry and the overall market, ROCKWELL MEDICAL INC's return on equity significantly trails that of both the industry average and the S&P 500.
- The gross profit margin for ROCKWELL MEDICAL INC is currently extremely low, coming in at 12.60%. It has decreased from the same quarter the previous year. Along with this, the net profit margin of -91.35% is significantly below that of the industry average.
- Net operating cash flow has significantly decreased to -$21.53 million or 232.03% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
- The debt-to-equity ratio of 1.16 is relatively high when compared with the industry average, suggesting a need for better debt level management. Despite the company's weak debt-to-equity ratio, the company has managed to keep a very strong quick ratio of 2.71, which shows the ability to cover short-term cash needs.
- ROCKWELL MEDICAL INC has improved earnings per share by 34.5% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, ROCKWELL MEDICAL INC reported poor results of -$2.64 versus -$1.20 in the prior year. This year, the market expects an improvement in earnings (-$1.24 versus -$2.64).
- You can view the full Rockwell Medical Ratings Report.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.